William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE) Jul 13, 2022 04:11PM
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022 Jul 11, 2022 04:01PM
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022 Jul 11, 2022 04:01PM
Xenon's (XENE) XEN1101 Has Best in Class Potential, Company is Trading at Attractive Value - William Blair Bullish on Stock Jun 23, 2022 06:06AM
Xenon's (XENE) X-Tole Data as Good as it Gets with Best-in-Category Efficacy - Analyst Oct 4, 2021 08:56AM


Jul 13, 2021 08:45AM Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
Jul 13, 2021 08:45AM Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 10, 2021 05:49AM Xenon Pharmaceuticals (XENE) Prices 4.32M Share Common Offering at $18.50/Sh
Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
Mar 9, 2021 04:05PM Xenon Pharmaceuticals (XENE) to Offer Common Stock
Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
Aug 4, 2020 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 4, 2020 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Jan 8, 2020 05:59AM William Blair Starts Xenon Pharmaceuticals (XENE) at Outperform